160 related articles for article (PubMed ID: 14599815)
1. Characterization of in vitro and in vivo gene transfer properties of adenovirus serotype 35 vector.
Sakurai F; Mizuguchi H; Yamaguchi T; Hayakawa T
Mol Ther; 2003 Nov; 8(5):813-21. PubMed ID: 14599815
[TBL] [Abstract][Full Text] [Related]
2. Efficient gene transfer into human CD34+ cells by an adenovirus type 35 vector.
Sakurai F; Mizuguchi H; Hayakawa T
Gene Ther; 2003 Jun; 10(12):1041-8. PubMed ID: 12776162
[TBL] [Abstract][Full Text] [Related]
3. Adenovirus serotype 35 vector-induced innate immune responses in dendritic cells derived from wild-type and human CD46-transgenic mice: Comparison with a fiber-substituted Ad vector containing fiber proteins of Ad serotype 35.
Sakurai F; Nakashima K; Yamaguchi T; Ichinose T; Kawabata K; Hayakawa T; Mizuguchi H
J Control Release; 2010 Dec; 148(2):212-8. PubMed ID: 20800630
[TBL] [Abstract][Full Text] [Related]
4. Development of adenovirus serotype 35 as a gene transfer vector.
Seshidhar Reddy P; Ganesh S; Limbach MP; Brann T; Pinkstaff A; Kaloss M; Kaleko M; Connelly S
Virology; 2003 Jul; 311(2):384-93. PubMed ID: 12842627
[TBL] [Abstract][Full Text] [Related]
5. Adenovirus vectors containing chimeric type 5 and type 35 fiber proteins exhibit altered and expanded tropism and increase the size limit of foreign genes.
Mizuguchi H; Hayakawa T
Gene; 2002 Feb; 285(1-2):69-77. PubMed ID: 12039033
[TBL] [Abstract][Full Text] [Related]
6. [Development of a replication-incompetent adenovirus vector derived from subgroup B adenovirus serotype 35].
Sakurai F
Yakugaku Zasshi; 2008 Dec; 128(12):1751-61. PubMed ID: 19043294
[TBL] [Abstract][Full Text] [Related]
7. Efficient gene delivery in human and rodent mast cells using adenovirus vectors.
Nakashima K; Sakurai F; Kawabata K; Mizuguchi H
J Control Release; 2008 Aug; 129(3):215-22. PubMed ID: 18572269
[TBL] [Abstract][Full Text] [Related]
8. Development and evaluation of a novel gene delivery vehicle composed of adenovirus serotype 35.
Sakurai F
Biol Pharm Bull; 2008 Oct; 31(10):1819-25. PubMed ID: 18827334
[TBL] [Abstract][Full Text] [Related]
9. [Characterization of adenovirus serotype 35 vectors using genetically modified animals and non-human primates].
Sakurai F; Kawabata K; Mizuguchi H
Yakugaku Zasshi; 2006 Nov; 126(11):1013-9. PubMed ID: 17077607
[TBL] [Abstract][Full Text] [Related]
10. Influence of coagulation factor x on in vitro and in vivo gene delivery by adenovirus (Ad) 5, Ad35, and chimeric Ad5/Ad35 vectors.
Greig JA; Buckley SM; Waddington SN; Parker AL; Bhella D; Pink R; Rahim AA; Morita T; Nicklin SA; McVey JH; Baker AH
Mol Ther; 2009 Oct; 17(10):1683-91. PubMed ID: 19603000
[TBL] [Abstract][Full Text] [Related]
11. Adenovirus serotype 35 vector-mediated transduction following direct administration into organs of nonhuman primates.
Sakurai F; Nakamura SI; Akitomo K; Shibata H; Terao K; Kawabata K; Hayakawa T; Mizuguchi H
Gene Ther; 2009 Feb; 16(2):297-302. PubMed ID: 18800152
[TBL] [Abstract][Full Text] [Related]
12. Enhanced transduction efficiency of fiber-substituted adenovirus vectors by the incorporation of RGD peptides in two distinct regions of the adenovirus serotype 35 fiber knob.
Matsui H; Sakurai F; Katayama K; Kurachi S; Tashiro K; Sugio K; Kawabata K; Mizuguchi H
Virus Res; 2011 Jan; 155(1):48-54. PubMed ID: 20801174
[TBL] [Abstract][Full Text] [Related]
13. Alternate serotype adenovector provides long-term therapeutic gene expression in the eye.
Hamilton MM; Byrnes GA; Gall JG; Brough DE; King CR; Wei LL
Mol Vis; 2008; 14():2535-46. PubMed ID: 19122827
[TBL] [Abstract][Full Text] [Related]
14. Transduction properties of adenovirus serotype 35 vectors after intravenous administration into nonhuman primates.
Sakurai F; Nakamura S; Akitomo K; Shibata H; Terao K; Kawabata K; Hayakawa T; Mizuguchi H
Mol Ther; 2008 Apr; 16(4):726-33. PubMed ID: 18362928
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the efficiency of transduction of leukemic cells by fiber-modified adenoviruses.
Yotnda P; Zompeta C; Heslop HE; Andreeff M; Brenner MK; Marini F
Hum Gene Ther; 2004 Dec; 15(12):1229-42. PubMed ID: 15684699
[TBL] [Abstract][Full Text] [Related]
16. Adenovirus 5-fiber 35 chimeric vector mediates efficient apical correction of the cystic fibrosis transmembrane conductance regulator defect in cystic fibrosis primary airway epithelia.
Granio O; Ashbourne Excoffon KJ; Henning P; Melin P; Norez C; Gonzalez G; Karp PH; Magnusson MK; Habib N; Lindholm L; Becq F; Boulanger P; Zabner J; Hong SS
Hum Gene Ther; 2010 Mar; 21(3):251-69. PubMed ID: 19788389
[TBL] [Abstract][Full Text] [Related]
17. A capsid-modified, conditionally replicating oncolytic adenovirus vector expressing TRAIL Leads to enhanced cancer cell killing in human glioblastoma models.
Wohlfahrt ME; Beard BC; Lieber A; Kiem HP
Cancer Res; 2007 Sep; 67(18):8783-90. PubMed ID: 17875719
[TBL] [Abstract][Full Text] [Related]
18. Adenovirus serotype 35 vector-mediated transduction into human CD46-transgenic mice.
Sakurai F; Kawabata K; Koizumi N; Inoue N; Okabe M; Yamaguchi T; Hayakawa T; Mizuguchi H
Gene Ther; 2006 Jul; 13(14):1118-26. PubMed ID: 16541121
[TBL] [Abstract][Full Text] [Related]
19. Adenoviral serotype 5 vectors pseudotyped with fibers from subgroup D show modified tropism in vitro and in vivo.
Denby L; Work LM; Graham D; Hsu C; von Seggern DJ; Nicklin SA; Baker AH
Hum Gene Ther; 2004 Nov; 15(11):1054-64. PubMed ID: 15610606
[TBL] [Abstract][Full Text] [Related]
20. In vitro and in vivo properties of adenovirus vectors with increased affinity to CD46.
Wang H; Liu Y; Li Z; Tuve S; Stone D; Kalyushniy O; Shayakhmetov D; Verlinde CL; Stehle T; McVey J; Baker A; Peng KW; Roffler S; Lieber A
J Virol; 2008 Nov; 82(21):10567-79. PubMed ID: 18753195
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
